Display Settings:

Format

Send to:

Choose Destination
    In Vivo. 2005 Jan-Feb;19(1):293-300.

    Anticancer compounds and sphingolipid metabolism in the colon.

    Source

    Gastroenterology Laboratory, Biomedical Centre, Lund University, S-221 84 Lund, Sweden. Rui-dong.duan@med.lu.se

    Abstract

    Sphingomyelin metabolism generates anticancer signals such as ceramide and sphingosine that may inhibit cell proliferation, and induce differentiation and apoptosis. Changes of sphingomyelin metabolism are found to be associated with tumorigenesis in various tissues and a particular link between sphingomyelin metabolism and colon cancer has been indicated. The effects of several anticancer drugs on sphingomyelin metabolism have been examined recently and there is an increasing interest in discovering new drugs taking sphingomyelin as a target. The present review outlines the sphingomyelin metabolism pathway, introduces the evidence linking sphingomyelin to colon cancer, and summarizes the anticancer drugs and dietary factors that affect the metabolism of sphingomyelin and, thus, the production of the anticancer messengers in the colon.

    PMID:
    15796189
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk